Clinical Research

Concurrent with the considerable advances in medical approaches for the treatment of patients with heart disease, there has also been steady evolution in the design of randomized clinical trials to assess new therapies. In part, this progress represents an outgrowth of the thrombolytic era, with more than 200,000 patients randomized in large-scale trials over the past decade, making thrombolysis the most intensively studied medical intervention to date.

“HLA match and other immunological parameters in relation to survival, rejection severity, and accelerated coronary artery disease after heart transplant”

Marilyn S. Pollack, Christie M. Ballantyne, Charlotte Payton-Ross, Beth Cocanougher, Steven K. Rowe, Gloria J. Grant, John A. Farmer, George P. Noon, Donald G. Weilbaecher, Damien Flores and James B. Young

The Multi·Organ Transplant Center of The Methodist Hospital and Baylor College of Medicine, Houston, TX, U.S.A. 

Learn More >>

More Clinical Trials will be added soon.